GMO International Qualit... Aktie - QLTI

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

24,3193

Gebot

Fragen

Volumen

32.844

24,21 Tagesbereich 24,45

22,49 52-Wochen-Bereich 25,46

Handelsende

24,45

Handelsbeginn

24,45

Letzte Trade

100

24.3193

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

23.224

Finanzvolumen

US$ 798.449

VWAP

24,3104

QLT Inc. establishes sales force in the United States

- QLT Ophthalmics, Inc. will market Visudyne(R) to retinal specialists across the U.S.- VANCOUVER, Dec. 22 /PRNewswire-FirstCall/ -- QLT Inc...

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

VANCOUVER, Dec. 15 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has initiated...

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

VANCOUVER, Dec. 9 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") welcomed the 6-month results from the...

QLT announces MGH litigation settlement

VANCOUVER, Nov. 25 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced the settlement of its...

QLT announces Toronto Stock Exchange approval of share repurchase program

VANCOUVER, Oct. 28 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT") announced that the Toronto Stock Exchange ("TSX") has...

QLT Announces Share Repurchase Program

VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that its board of...

QLT announces third quarter results for 2009

QLT SEPARATELY ANNOUNCES SHARE REPURCHASE PROGRAM VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the...

QLT restructures Visudyne(R) agreement

RECEIVES EXCLUSIVE U.S. RIGHTS AND WILL RECEIVE A ROYALTY ON SALES OUTSIDE THE U.S. VANCOUVER, Oct. 19 /PRNewswire-FirstCall/ -- QLT Inc...

QLT announces sale of QLT USA, Inc. for up to US$230 million

VANCOUVER, Oct. 1 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has completed the...

QLT announces receipt of a CDN$45.3 million tax refund

VANCOUVER, Sept. 8 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has received an...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.8307	-3.30298210736	25.15	25.28	24.22	125242	24.72265949	SP
4	0.1793	0.742750621375	24.14	25.35	23.97	38160	24.68677565	SP
12	0.3593	1.49958263773	23.96	25.46	22.49	23224	24.12770839	SP
26	-0.5307	-2.13561368209	24.85	25.46	22.49	17947	24.08051891	SP
52	-0.5307	-2.13561368209	24.85	25.46	22.49	17947	24.08051891	SP
156	-0.5307	-2.13561368209	24.85	25.46	22.49	17947	24.08051891	SP
260	-0.5307	-2.13561368209	24.85	25.46	22.49	17947	24.08051891	SP

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
DP8CervoMed Inc	6,25 € (192,06%)	123,89k
49QZenatech Inc	4,86 € (86,92%)	3,67k
M0YNMynaric AG	1,305 € (79,26%)	1,26M
7IPImpro Precision Industries Limited	0,478 € (61,49%)	750
D7GNel ASA	0,3199 € (61,16%)	66,72M
WIG1Wige Media AG	0,034 € (-64,77%)	1,49M
GTYGateway Real Estate AG	0,30 € (-42,31%)	30,37k
I8RIrobot Corp Dl 01	3,735 € (-35,87%)	116,47k
0S90Syros Pharmaceuticals Inc	0,0715 € (-32,55%)	68,93k
NL8Genesis Ai Corp	0,01 € (-31,51%)	205,46k
D7GNel ASA	0,3199 € (61,16%)	66,72M
UH7ATennant Minerals NL	0,0075 € (-16,67%)	3,6M
3CPXiaomi Corporation	6,20 € (-3,28%)	1,72M
TKAThyssenkrupp AG	8,71 € (2,16%)	1,71M
PUMPuma SE	22,68 € (-14,09%)	1,68M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

GMO International Quality ETF (QLTI)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

QLTI Neueste Nachrichten

QLT Inc. establishes sales force in the United States

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

QLT announces MGH litigation settlement

QLT announces Toronto Stock Exchange approval of share repurchase program

QLT Announces Share Repurchase Program

QLT announces third quarter results for 2009

QLT restructures Visudyne(R) agreement

QLT announces sale of QLT USA, Inc. for up to US$230 million

QLT announces receipt of a CDN$45.3 million tax refund

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

GMO International Quality ETF (QLTI) Börsenkurse

GMO International Quality ETF (QLTI)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

QLTI Neueste Nachrichten

QLT Inc. establishes sales force in the United States

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

QLT announces MGH litigation settlement

QLT announces Toronto Stock Exchange approval of share repurchase program

QLT Announces Share Repurchase Program

QLT announces third quarter results for 2009

QLT restructures Visudyne(R) agreement

QLT announces sale of QLT USA, Inc. for up to US$230 million

QLT announces receipt of a CDN$45.3 million tax refund

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen